CRL Competitors & Alternatives
Compare Charles River Laboratories with similar stocks in the same industry
Diagnostics & Research
CRL
Main Stock$344.87
Tradestie Score
33
Market Cap
$8.39B
Revenue Growth
0.0%
Analyst Upside
-8.5%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DGX
Quest Diagnostics Inc.
|
$238.93
|
$20.36B | 25.2 | 69 | Compare |
|
WST
West Pharmaceutical Services, Inc.
|
$393.48
|
$19.52B | 49.8 | 37 | Compare |
|
WAT
Waters Corp
|
$457.47
|
$19.04B | 112.1 | 41 | Compare |
|
ILMN
Illumina Inc
|
$282.86
|
$15.72B | 50.0 | 42 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$662.48
|
$15.28B | 36.5 | 46 | Compare |
|
ICLR
Icon Plc
|
$185.25
|
$14.96B | 177.7 | 37 | Compare |
|
COO
The Cooper Companies, Inc. Common Stock
|
$58.97
|
$13.53B | 20.3 | 49 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
|
RVTY
Revvity, Inc.
|
$156.61
|
$10.65B | 74.6 | 48 | Compare |
|
QGEN
QIAGEN N.V.
|
$50.00
|
$10.04B | 24.8 | 47 | Compare |
More CRL Analysis
Data updated: Oct 22, 2026 | Industry: Diagnostics & Research (SIC 8731)
38 stocks in this industry